抗组织蛋白酶D(CTSD)单克隆抗体
Anti-Cathepsin D (CTSD) Monoclonal Antibody
CPSD; CLN10; Lysosomal Aspartyl Protease; Ceroid-Lipofuscinosis,Neuronal 10
用法
Western blotting: 0.2-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Flow cytometry:10μg/ml;
Optimal working dilutions must be determined by end user.
储存
经常使用则4°C保存。-20°C保存不超过一年。避免反复冻融。
赠品
增值服务
相关产品
| 编号 | 适用物种:Homo sapiens (Human,人) | 应用(仅供研究使用,不用于临床诊断!) |
| APB280Hu61 | 组织蛋白酶D(CTSD)活性蛋白 | Cell culture; Activity Assays. |
| EPB280Hu61 | 组织蛋白酶D(CTSD)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB280Hu01 | 组织蛋白酶D(CTSD)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APB280Hu62 | 组织蛋白酶D(CTSD)活性蛋白 | Cell culture; Activity Assays. |
| EPB280Hu62 | 组织蛋白酶D(CTSD)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB280Hu02 | 组织蛋白酶D(CTSD)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB280Hu03 | 组织蛋白酶D(CTSD)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB280Hu04 | 组织蛋白酶D(CTSD)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB280Hu02 | 组织蛋白酶D(CTSD)多克隆抗体 | WB; IHC; ICC; IP. |
| PAB280Hu01 | 组织蛋白酶D(CTSD)多克隆抗体 | WB; IHC; ICC; IP. |
| LAB280Hu71 | 组织蛋白酶D(CTSD)多克隆抗体(生物素标记) | WB; IHC; ICC. |
| MAB280Hu21 | 组织蛋白酶D(CTSD)单克隆抗体 | ICC/IF |
| MAB280Hu26 | 组织蛋白酶D(CTSD)单克隆抗体 | WB |
| MAB280Hu22 | 组织蛋白酶D(CTSD)单克隆抗体 | WB; IHC; ICC/IF |
| FAB280Hu02 | 抗组织蛋白酶D(CTSD)单克隆抗体 | Flow cytometry. |
| SEB280Hu | 组织蛋白酶D(CTSD)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| HEB280Hu | 组织蛋白酶D(CTSD)检测试剂盒(酶联免疫吸附试验法,高敏型) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB280Hu | 组织蛋白酶D(CTSD)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
| 杂志 | 参考文献 |
| Molecular Immunology | Cathepsin D is released after severe tissue trauma in vivo and is capable of generating C5a in vitro[ScienceDirect: S0161589011008297] |
| 21 | Plasma Cathepsin D Levels: A Novel Tool to Predict Pediatric Hepatic Inflammation[PubMed: 25732418] |
| Scientific Reportes | Plasma cathepsin D correlates with histological classifications of fatty liver disease in adults and responds to intervention[pubmed:27922112] |
| Biomedicine & pharmacotherapy | Berberine ameliorates intrahippocampal kainate-induced status epilepticus and consequent epileptogenic process in the rat: Underlying mechanisms[pubmed:28061403] |
| JGH OPEN | Limited applicability of cathepsin D for the diagnosis and monitoring of non‐alcoholic steatohepatitis[] |
| Diabetologia | Plasma cathepsin D activity is negatively associated with hepatic insulin sensitivity in overweight and obese humans[Pubmed: 31690989] |
| Antioxidants | Iron and Advanced Glycation End Products: Emerging Role of Iron in Androgen Deficiency in Obesity[Pubmed: 32235809] |
| Peptides | LVV-hemorphin-7 (LVV-H7) plays a role in antinociception in a rat model of alcohol-induced pain disorders[33253777] |
| Cells | Identification of Cathepsin D as a Plasma Biomarker for Alzheimer's Disease[33445607] |
| J Chem Neuroanat | Analysis of silymarin-modulating effects against acrylamide-induced cerebellar damage in male rats: Biochemical and pathological markers[33965515] |
| Front Cell Infect Microbiol | PGRS Domain of Rv0297 of Mycobacterium tuberculosis Is Involved in Modulation of Macrophage Functions to Favor Bacterial Persistence[33042856] |
| Nutr Metab Cardiovasc Dis | Serum CathepsinD in pregnancy: relation with metabolic and inflammatory markers and effects of fish oils and probiotics[Pubmed:35304048] |
| Biosensors | A Comparison of Various Chips Used for the Manufacture of Biosensors Applied in Non-Fluidic Array SPRi, Based on the Example of Determination of Cathepsin D[Pubmed:35049649] |



